You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oxaliplatin and gemcitabine chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Durvalumab
  • +7 more
  • Orange, California
  • +36 more
Mar 6, 2023

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital affiliated to Fudan University
Aug 12, 2022

Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • Hamilton, Ontario, Canada
    Juravinski Hospital
Aug 5, 2022

Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2023

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (oxaliplatin , fluorouracil, and leucovorin, gemcitabine and cisplatin)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • oxaliplatin , fluorouracil, and leucovorin
  • gemcitabine and cisplatin
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jul 7, 2021

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (combined therapy using oxaliplatin and gemcitabine chemo, Lenvatinib and PD1

Active, not recruiting
  • Cholangiocarcinoma, Intrahepatic
  • combined therapy using oxaliplatin and gemcitabine chemotherapy, Lenvatinib and PD1 antibody (JS001)
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jul 5, 2021

Metastatic Solid Tumor, NSCLC, Gastric Cancer Trial (RO7496353, Atezolizumab, Capecitabine)

Not yet recruiting
  • Metastatic Solid Tumor
  • +3 more
  • (no location specified)
May 22, 2023

Recurrent DLBCL, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory DLBCL Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +5 more
  • Duarte, California
  • +3 more
Nov 17, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • +7 more
  • Gemcitabine Hydrochloride
  • +8 more
  • Philadelphia, Pennsylvania
  • +1 more
Dec 20, 2022

Advanced Solid Tumors Trial in Shanghai (HLX07+Gemcitabine+Cisplatin, HLX07+Paclitaxel+Carboplatin, HLX07+mFOLFOX6)

Active, not recruiting
  • Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
May 5, 2022

Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

Recruiting
  • Diffuse Large B-cell Lymphoma Recurrent
  • Diffuse Large B Cell Lymphoma Refractory
  • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 12, 2023

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Pancreatic Ductal Adenocarcinoma Trial in Germany (Oxaliplatin, Irinotecan, Folinic acid)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Aachen, Germany
  • +27 more
May 19, 2022

Colorectal Cancer, Cholangiocarcinoma Trial in United States (Medtronic pump and Codman catheter, Floxuridine (FUDR),

Active, not recruiting
  • Colorectal Cancer
  • Cholangiocarcinoma
  • Medtronic pump and Codman catheter
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 3, 2022

Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States

Completed
  • Biliary Tract Cancer (BTC)
  • +5 more
  • Birmingham, Alabama
  • +9 more
Dec 22, 2022

Biliary Tract Carcinoma Trial in Shanghai (Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab)

Recruiting
  • Biliary Tract Carcinoma
  • Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 25, 2022

CNS Germ Cell Tumor Trial in United States (Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).)

Completed
  • CNS Germ Cell Tumor
  • Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).
  • Phoenix, Arizona
  • +4 more
Jan 5, 2021

Locally Advanced and Metastatic Pancreatic Cancer Trial in Shanghai (PD-L1/CTLA4 BsAb, GP, FOLFIRINOX)

Recruiting
  • Locally Advanced and Metastatic Pancreatic Cancer
  • PD-L1/CTLA4 BsAb
  • +2 more
  • Shanghai, Shanghai, China
    Changhai hospital
Aug 3, 2021

Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +19 more
Dec 8, 2022

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type, Early-stage, High-Risk Cancer Trial in Beijing (Anti-PD-1 mAb,

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • +2 more
  • Anti-PD-1 monoclonal antibody
  • +4 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Feb 23, 2022

Cholangiocarcinoma Trial in Herlev (Oxaliplatin, capecitabine, gemcitabine, cetuximab, Oxaliplatin, capecitabine, gemcitabine

Completed
  • Cholangiocarcinoma
  • Oxaliplatin, capecitabine, gemcitabine, cetuximab
  • Oxaliplatin, capecitabine, gemcitabine cetuximab
  • Herlev, Denmark
    Herlev Hospital
Oct 1, 2020

Solid Tumor Trial in Shanghai (HB002.1T, Oxaliplatin, Capecitabine)

Recruiting
  • Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jul 26, 2021

Peritoneal Carcinomatosis, Pancreas Tumor Trial in Rome (Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy

Recruiting
  • Peritoneal Carcinomatosis
  • Pancreas Neoplasm
  • Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 11, 2023

Chemotherapy mFOLFIRINOX in Locally Advanced or Metastatic

Unknown status
  • Cholangiocarcinoma of the Bile Duct
    • Shanghai, Shanghai, China
      Xinhua Hospital
    Dec 30, 2020